Menarini Silicon Biosystems.: Menarini Silicon Biosystems announces new study results on use of CELLSEARCH liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

Results of this MD Anderson study were recently published in Cancers and indicate the relevance of enumeration of Circulating Tumor Cells (CTCs) with the minimally invasive liquid biopsy-based CELLSEARCH® system to gain significantly earlier information, compared to standard imaging techniques, on the evolution of advanced skin cancer. BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Oct. 3, 2023 [...] The post Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma first appeared on LifeCareNews.